ZEMASIN 25MG TABLETS

Zemasin 25mg Tablets are a prescription aromatase inhibitor specifically designed for the treatment of hormone receptor-positive breast cancer in postmenopausal women. By lowering estrogen levels in the body, Zemasin helps slow or halt the growth of estrogen-dependent cancer cells, supporting long-term cancer management.

The active ingredient, exemestane, works by blocking the aromatase enzyme responsible for converting androgens into estrogen. This targeted mechanism makes Zemasin an effective hormonal therapy option to reduce the risk of cancer progression or recurrence in postmenopausal patients.

Zemasin 25 mg Tablets are a prescription product carefully formulated to deliver consistent potency and safety for long-term hormonal therapy in postmenopausal women with breast cancer. This product is used under strict oncologist supervision to help control estrogen-dependent cancer growth and support effective, ongoing cancer management.

Product Features

• Hormonal anticancer therapy tablet
• Contains Exemestane 25 mg
• Aromatase inhibitor for breast cancer treatment
• Used in postmenopausal women
• Oral tablet dosage form
• Suitable for long-term hormonal therapy
• Manufactured under strict pharmaceutical quality standards
• Prescription-required medication

How It Helps

• Reduces estrogen levels to slow or stop estrogen-dependent cancer growth
• Supports long-term hormonal therapy in postmenopausal women
• Helps lower the risk of breast cancer recurrence
• Provides targeted anticancer treatment with minimal systemic effects